Blog

Rare Disease Drugs Can Be Costly; Here Are Ways to Ease the Financial Burden

Published 1.5.2023 | Written By The Star Malaysia

The Star Malaysia explored the financial burden of rare-disease medicines and highlighted patient-assistance and support programs as potential pathways to making costly treatments more accessible.

Learn More

Resources

Related Blogs

View All

Blog Global

Why Traditional Access Models Don’t Work for Rare Diseases, and What Needs to Change

Blog Global

ISPOR 2026: What Happens When Global Market Access Strategies Meet Local Reality?

Blog Global

Dr. Saba Speaks on Priorities and Challenges in Polish and European Drug Policy

Subscribe to Our Insights